<code id='A4F5615649'></code><style id='A4F5615649'></style>
    • <acronym id='A4F5615649'></acronym>
      <center id='A4F5615649'><center id='A4F5615649'><tfoot id='A4F5615649'></tfoot></center><abbr id='A4F5615649'><dir id='A4F5615649'><tfoot id='A4F5615649'></tfoot><noframes id='A4F5615649'>

    • <optgroup id='A4F5615649'><strike id='A4F5615649'><sup id='A4F5615649'></sup></strike><code id='A4F5615649'></code></optgroup>
        1. <b id='A4F5615649'><label id='A4F5615649'><select id='A4F5615649'><dt id='A4F5615649'><span id='A4F5615649'></span></dt></select></label></b><u id='A4F5615649'></u>
          <i id='A4F5615649'><strike id='A4F5615649'><tt id='A4F5615649'><pre id='A4F5615649'></pre></tt></strike></i>

          entertainment

          entertainment

          author:hotspot    Page View:4
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more
          Readout Newsletter: Merck, J&J, and long Covid
          Readout Newsletter: Merck, J&J, and long Covid

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo

          read more
          Anesthesiologist group: stop taking Ozempic before surgery
          Anesthesiologist group: stop taking Ozempic before surgery

          EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

          read more

          Readout Newsletter: Merck, J&J, and long Covid

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo